Screening for renal insufficiency: Is it worth while? Is it feasible?

Nephrology Dialysis Transplantation

Volumn 14, Issue 9, 1999, Pages 2082-2084

  Jungers, Paul ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; EDITORIAL; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MASS SCREENING; PRIORITY JOURNAL; PUBLIC HEALTH;

EVALUATION STUDIES; FEASIBILITY STUDIES; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MASS SCREENING; PUBLIC HEALTH; RISK FACTORS;

EID: 0032781032     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.9.2082     Document Type: Editorial

References (12)

1. Obrador GT, Pereira BJG. Early referral to the nephrologist and timely initiation of renal replacement therapy: A paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis 1998; 31: 398-417
2. Eadington DW. Delayed referral for dialysis. Nephrol Dial Transplant 1996; 11: 2124-2126
3. Jungers P, Zingraff J, Albouze G et al. Late referral to maintenance dialysis: detrimental consequences. Nephrol Dial Transplant 1993; 8: 1089-1093
4. Hood SA, Sondheimer JH. Impact of pre-ESRD management on dialysis outcomes: a review. Semin Dial 1998; 11: 175-180
5. Jungers P, Massy Z, Nguyen-Khoa T et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 1997; 12: 2597-2602
6. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462
7. Kissmeyer L, Kong C, Cohen J, Unwing RJ, Waolson RG, Neild GH. Community nephrology: audit of screening for renal insufficiency in a high risk population. Nephrol Dial Transplant 1999; 14:
8. Klahr S, Levey AS, Beck GJ et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 1994; 330: 877-884
9. Giatras I, Lau J, Levey AS. Effect of angiotensin-converting enzyme inhibitors on the progression of non-diabetic renal disease: a meta-analysis of randomized trials. Ann Intern Med 1997; 127: 337-345
10. NIH consensus statement: Morbidity and mortality of renal dialysis. Ann Intern Med 1994; 121: 62-70
11. Levey AS, Eknoyan G. Cardiovascular disease in chronic renal disease. Nephrol Dial Transplant 1999; 14: 828-833
12. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339: 1448-1456